Q&A: Renier Brentjens on Obstacles and Opportunities in CAR T-cell Therapy

Key Points

• The focus is on understanding the challenges and advancements in CAR T-cell therapy.
• Interview with Renier Brentjens, an expert in CAR T-cell therapy
• Discussion of early work in CAR T technologies
• Exploration of current limitations and future directions of research
• Identification of key limitations in current CAR T-cell therapies
• Suggestions for future advancements in CAR T technology
• Insight into ongoing research efforts to improve treatment outcomes